These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 9822356)
1. Renal tolerability of teicoplanin in a case of neonatal overdose. Fanos V; Mussap M; Khoory BJ; Vecchini S; Plebani M; Benini D J Chemother; 1998 Oct; 10(5):381-4. PubMed ID: 9822356 [TBL] [Abstract][Full Text] [Related]
2. Enhanced loading regimen of teicoplanin is necessary to achieve therapeutic pharmacokinetics levels for the improvement of clinical outcomes in patients with renal dysfunction. Ueda T; Takesue Y; Nakajima K; Ichiki K; Doita A; Wada Y; Tsuchida T; Takahashi Y; Ishihara M; Ikeuchi H; Uchino M; Kimura T Eur J Clin Microbiol Infect Dis; 2016 Sep; 35(9):1501-9. PubMed ID: 27278654 [TBL] [Abstract][Full Text] [Related]
3. Experience with teicoplanin in the treatment of neonatal staphylococcal sepsis. Yalaz M; Cetin H; Akisu M; Yeniay B; Tunger A; Kultursay N J Int Med Res; 2004; 32(5):540-8. PubMed ID: 15458287 [TBL] [Abstract][Full Text] [Related]
4. [Pharmacokinetic and clinical studies on teicoplanin for sepsis by methicillin-cephem resistant Staphylococcus aureus in the pediatric and neonate field]. Sunakawa K; Nonoyama M; Fujii R; Iwai N; Sakata H; Shirai M; Sato T; Kajino M; Toyonaga Y; Sano T; Naito A; Minagawa K; Niida Y; Oda T; Yokozawa M; Asanuma H; Shimura K; Fujimura M; Kitajima H; Fujinami K; Numazaki K; Fujikawa T; Kobayashi Y; Sato Y; Nishimura T; Iwata S; Tsuchihashi N; Oishi T; Matsumoto S; Motohiro T; Osawa M; Sunahara M; Shirakawa S; Nishida H; Takahashi N; Nakano R; Sai N; Iyoda K; Yoshimitsu K; Ogawa K; Okazaki T; Tsukimoto I; Motoyama O; Takada Y; Kawasaki M; Sunaoshi W; Nakamura S; Ueda Y; Kamata M; Kato T; Chiba M; Ouchi K; Sato S; Horiuchi T; Suzuki K; Shimoyama T; Masaki H; Aikyo M; Kawada M; Banba M; Furukawa S; Okada T; Yamaguchi S; Hirota O; Koizumi S; Wada H; Ohta K; Uehara T; Yukitake K; Mori T; Takakuwa S; Matsuyama K Jpn J Antibiot; 2002 Oct; 55(5):656-77. PubMed ID: 12532639 [TBL] [Abstract][Full Text] [Related]
5. Significance of individual adjustment of initial loading dosage of teicoplanin based on population pharmacokinetics. Niwa T; Imanishi Y; Ohmori T; Matsuura K; Murakami N; Itoh Y Int J Antimicrob Agents; 2010 May; 35(5):507-10. PubMed ID: 20185275 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic Drug Monitoring Simulator for Antibiotic Dosage for Methicillin-Resistant Staphylococcus aureus Sepsis in a Patient with Primary Immunodeficiency on Peritoneal Dialysis. Narazaki H; Terada Y; Kaizu K; Jitsukawa T; Ito Y; Asano T J Nippon Med Sch; 2017; 84(4):177-182. PubMed ID: 28978898 [TBL] [Abstract][Full Text] [Related]
7. High-dose regimen to achieve novel target trough concentration in teicoplanin. Ueda T; Takesue Y; Nakajima K; Ichki K; Wada Y; Komatsu M; Tsuchida T; Takahashi Y; Ishihara M; Kimura T; Uchino M; Ikeuchi H J Infect Chemother; 2014 Jan; 20(1):43-7. PubMed ID: 24462424 [TBL] [Abstract][Full Text] [Related]
8. Simplified dosing regimens of teicoplanin for patient groups stratified by renal function and weight using Monte Carlo simulation. Yamada T; Nonaka T; Yano T; Kubota T; Egashira N; Kawashiri T; Oishi R Int J Antimicrob Agents; 2012 Oct; 40(4):344-8. PubMed ID: 22818770 [TBL] [Abstract][Full Text] [Related]
9. Development of a teicoplanin loading regimen that rapidly achieves target serum concentrations in critically ill patients with severe infections. Nakamura A; Takasu O; Sakai Y; Sakamoto T; Yamashita N; Mori S; Morita T; Nabeta M; Hirayu N; Yoshiyama N; Moroki M; Tashiro K; Kannae M J Infect Chemother; 2015 Jun; 21(6):449-55. PubMed ID: 25726436 [TBL] [Abstract][Full Text] [Related]
10. Successful treatment of right-sided native valve methicillin-resistant Staphylococcus aureus endocarditis and septicaemia with teicoplanin and rifampicin: a case report. Saravu K; Mukhopadhyay C; Satyanarayanan V; Pai A; Komaranchath AS; Munim F; Shastry BA; Tom D Scand J Infect Dis; 2012 Jul; 44(7):544-7. PubMed ID: 22385220 [TBL] [Abstract][Full Text] [Related]
11. Receipt of supratherapeutic dalbavancin. Mahoney MV; Padival S Am J Health Syst Pharm; 2020 Feb; 77(5):326-328. PubMed ID: 31950151 [No Abstract] [Full Text] [Related]
12. Albumin concentration significantly impacts on free teicoplanin plasma concentrations in non-critically ill patients with chronic bone sepsis. Brink AJ; Richards GA; Lautenbach EE; Rapeport N; Schillack V; van Niekerk L; Lipman J; Roberts JA Int J Antimicrob Agents; 2015 Jun; 45(6):647-51. PubMed ID: 25819167 [TBL] [Abstract][Full Text] [Related]
13. [Teicoplanin therapy in neonatal and pediatric intensive therapy]. Tuo P; Tumolo M; Silvestri G; Vallarino R; Balzarini C; Barretta A; Mazzarello GF; Losurdo G; Mantero E; Fossa S Pediatr Med Chir; 1992; 14(2):151-4. PubMed ID: 1387207 [TBL] [Abstract][Full Text] [Related]
14. Use of teicoplanin in preterm neonates with staphylococcal late-onset neonatal sepsis. Degraeuwe PL; Beuman GH; van Tiel FH; Maertzdorf WJ; Blanco CE Biol Neonate; 1998; 73(5):287-94. PubMed ID: 9573458 [TBL] [Abstract][Full Text] [Related]
15. [Staphylococcal infection in the newborn: teicoplanin therapy]. Fanos V; Khoory BJ; Danieli D; Padovani EM Pediatr Med Chir; 1993; 15(6):579-82. PubMed ID: 8197017 [TBL] [Abstract][Full Text] [Related]
16. The efficacy and toxicity of two dosing-regimens of amikacin in neonates with sepsis. Abdel-Hady E; El Hamamsy M; Hedaya M; Awad H J Clin Pharm Ther; 2011 Feb; 36(1):45-52. PubMed ID: 21198719 [TBL] [Abstract][Full Text] [Related]